Cardiovascular Diabetology · Nov 3, 2026
Estimated glucose disposal rate and lipoprotein(a) as complementary markers of cardiovascular risk in the UK Biobank
By Wen S, Huang Z, Wang J et al.
Background Estimated glucose disposal rate (eGDR) summarizes waist circumference, hypertension, and glycated hemoglobin, whereas lipoprotein(a) [Lp(a)] reflects a largely inherited atherogenic pathway. We investigated their joint associations with cardiovascular disease (CVD) and examined whether either marker improves prediction beyond established risk factors. Methods We followed 286,025 UK Biobank participants without baseline CVD. Low eGDR was defined as ≤ 6.28 mg/kg/min and high Lp(a) as ≥ 125 nmol/L. Multivariable Cox models estimated individual and joint associations. Interaction was evaluated on relative hazard and competing-risk-adjusted 10-year absolute-risk scales, and prediction was assessed using fivefold cross-validation. Results During a median follow-up of 14.1 years, 34,921 participants developed CVD. The adjusted HRs were 1.37 (95% CI, 1.35–1.39) per 1-SD lower eGDR and 1.07 (95% CI, 1.06–1.08) per 1-SD higher log-Lp(a). Compared with high eGDR/low Lp(a), low eGDR/high Lp(a) was associated with an HR of 1.51 (95% CI, 1.43–1.59). Standardized 10-year cumulative incidence accounting for competing death was 7.15% and 10.45% in these groups, respectively; neither multiplicative interaction (P = 0.207) nor the 10-year absolute-risk interaction contrast (− 0.08% points; 95% CI, − 0.58 to 0.47) was significant. In a comprehensive risk-factor model, adding eGDR increased the C-index from 0.71048 to 0.71174, and further adding Lp(a) increased it to 0.71208, without clear additional decision-curve benefit. Conclusions Lower eGDR and higher Lp(a) were independently associated with incident CVD, and their combination identified participants at greatest risk without evidence of statistical interaction. Their incremental predictive value beyond comprehensive conventional risk assessment was small. Graphical Abstract